Vice President of Business Development
Justin To is the vice president of business development and operations at Aspa Therapeutics. He is also currently the director of portfolio operations at BridgeBio, where he has overseen the creation and buildup of five different companies, ranging from oncology to gene therapy in pediatric rare diseases. Prior to BridgeBio, Justin was a product commercialization manager at Flatiron Health, where he led their products for clinical trials in genetically-driven cancers. Prior to Flatiron, Justin was a consultant in McKinsey & Company’s Boston office, where he advised pharmaceutical and biotech clients on mergers, drug launch strategy, and business development strategy. He received his A.B. in chemistry, Magna Cum Laude with highest honors, from Harvard College.